← Eichor
Condition: Chronic Hepaititis B Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Chronic Hepaititis B

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Phase 1/2, Open-Label, Single and Multiple Ascending Dose Study of CRMA-1001 in Adults With Chronic Hepatitis B
Phase 1/Phase 2 · 4 location(s) · nChroma Bio · NCT07200193Immunomodulatory Therapy and Predictors of Clinical Cure in Chronic Hepatitis B
EARLY_Phase 1 · 1 location(s) · Peking University People's Hospital · NCT07328711Single-Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Pevifoscorvir Sodium (ALG-000184) in Sub
Phase 1 · 1 location(s) · Aligos Therapeutics · NCT07342868
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.